Table 3.
Characteristics of included studies
| Instrument | Instrument full-text availability | Instrument total number of items | Mean time to complete the instrument | Actual sample size (analysed data) |
|---|---|---|---|---|
| FACT-G [26] |
Yesa | 27 | NR | 975 |
| MDASI [29] |
Yesb | 19 | NR | 268 |
| VES-13 [30] |
Yesc | 13 | NR | 272 108d |
| EORTC QLQ-C-15-PAL [25] |
No | 15 | NR | 104 |
| SF-36 [27] |
No | 36 | NR | 106 99e 94f |
| WHOQOL-bref [27] |
No | 24 | NR | 106 99e 94f |
| EORTC QLQ-C30 [24] |
No | 30 | NR | 986 |
| ESAS [28] |
Yes | 10 | 2.24 min | 249 84g 80h |
NR not reported
a As per request to Functional Assessment of Chronic Illness Therapy (FACIT) Group
b In a separate publication [32]
c In a separate publication [33]
d Sample size for the reliability measurement (assessed 7 to 15 days after baseline)
e Sample size for the reliability measurement (assessed 48 h after baseline)
f Sample size for the responsiveness measurement (assessed 30 days after baseline)
g Sample size for the reliability measurement (assessed 4 to 96 h after baseline)
h Sample size for the responsiveness measurement (assessed 21±7 days after baseline)